LOCAL PHARMACY GROUP LIMITED

Company Registration Number:
14720337 (England and Wales)

Unaudited statutory accounts for the year ended 31 March 2024

Period of accounts

Start date: 10 March 2023

End date: 31 March 2024

LOCAL PHARMACY GROUP LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2024

Balance sheet
Additional notes
Balance sheet notes

LOCAL PHARMACY GROUP LIMITED

Balance sheet

As at 31 March 2024

Notes 13 months to 31 March 2024


£
Fixed assets
Intangible assets: 3 245,833
Tangible assets: 4 7,441
Total fixed assets: 253,274
Current assets
Stocks: 5 24,000
Debtors: 6 67,249
Cash at bank and in hand: 3,973
Total current assets: 95,222
Creditors: amounts falling due within one year: 7 ( 191,839 )
Net current assets (liabilities): (96,617)
Total assets less current liabilities: 156,657
Creditors: amounts falling due after more than one year: 8 ( 166,477 )
Total net assets (liabilities): (9,820)
Capital and reserves
Called up share capital: 2
Profit and loss account: (9,822 )
Total Shareholders' funds: ( 9,820 )

The notes form part of these financial statements

LOCAL PHARMACY GROUP LIMITED

Balance sheet statements

For the year ending 31 March 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen not to file a copy of the company's profit and loss account.

This report was approved by the board of directors on 29 April 2025
and signed on behalf of the board by:

Name: Alex O'Brien
Status: Director

The notes form part of these financial statements

LOCAL PHARMACY GROUP LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    Revenue recognition Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts. The company recognises revenue when: The amount of revenue can be reliably measured; it is probable that future economic benefits will flow to the entity; and specific criteria have been met for each of the company's activities

    Tangible fixed assets depreciation policy

    Depreciation Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows: Asset class Fixtures and fittings Office equipment Depreciation method and rate 25%per annum of cost 25%per annum of cost

    Intangible fixed assets amortisation policy

    Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows: Asset class Goodwill Amortisation method and rate Straight line over 10 Years

LOCAL PHARMACY GROUP LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2024

  • 2. Employees

    13 months to 31 March 2024
    Average number of employees during the period 3

LOCAL PHARMACY GROUP LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2024

3. Intangible assets

Goodwill Other Total
Cost £ £ £
Additions 250,000 250,000
Disposals
Revaluations
Transfers
At 31 March 2024 250,000 250,000
Amortisation
Charge for year 4,167 4,167
On disposals
Other adjustments
At 31 March 2024 4,167 4,167
Net book value
At 31 March 2024 245,833 245,833

LOCAL PHARMACY GROUP LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2024

4. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Motor vehicles Total
Cost £ £ £ £ £ £
Additions 583 7,159 7,742
Disposals
Revaluations
Transfers
At 31 March 2024 583 7,159 7,742
Depreciation
Charge for year 24 277 301
On disposals
Other adjustments
At 31 March 2024 24 277 301
Net book value
At 31 March 2024 559 6,882 7,441

LOCAL PHARMACY GROUP LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2024

5. Stocks

13 months to 31 March 2024
£
Stocks 24,000
Total 24,000

LOCAL PHARMACY GROUP LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2024

6. Debtors

13 months to 31 March 2024
£
Trade debtors 55,066
Prepayments and accrued income 3,778
Other debtors 8,405
Total 67,249

LOCAL PHARMACY GROUP LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2024

7. Creditors: amounts falling due within one year note

13 months to 31 March 2024
£
Bank loans and overdrafts 7,027
Trade creditors 38,963
Taxation and social security 3,020
Accruals and deferred income 1,000
Other creditors 141,829
Total 191,839

LOCAL PHARMACY GROUP LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2024

8. Creditors: amounts falling due after more than one year note

13 months to 31 March 2024
£
Bank loans and overdrafts 166,477
Total 166,477